Physician profile
James M Eule
NPI 1871540013
$17,026.65
in general payments reported to CMS, 2019-2025
11 companies · $21.99 in 2025
The $21.99 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,070 · 2020: $2,339 · 2021: $4,395 · 2022: $1,790 · 2023: $4,084 · 2024: $326 · 2025: $21.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,218 · Food and Beverage: $1,121 · Education: $92.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,217.96 |
| Food and Beverage | $1,121.46 |
| Education | $92.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $9,799.24 | 2019-2022 | |
| Cerapedics INC. | $3,640.08 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Medtronic, INC. | $2,216.01 | 2021-2024 | Cd Horizon Spinal System, Plasmablade(Tm), Mazor X System |
| Medtronic USA, INC. | $867.14 | 2019 | |
| Orthofix Medical, INC. | $270.47 | 2021-2022 | |
| Kci USA, INC. | $91.19 | 2022 | |
| Depuy Synthes Sales INC. | $50.05 | 2021-2022 | |
| Stryker Corporation | $36.78 | 2023 | Ozark Cervical Plate System |
| Heron Therapeutics, INC. | $21.99 | 2025 | Aponvie |
| Welch Allyn | $19.30 | 2020 | |
| Arthrex, INC. | $14.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Eule listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.